Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-100
SponsorGöteborg University

About this trial

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.

Eligibility criteria

Qualifiers

Age ≥18 years

Consents to participation in the study

Verified endometriosis (by laparoscopy or ultrasound).

Chronic endometriosis-related pain (> 3 months), available for TENS treatment

Disqualifiers

Patient with inability to understand and use written and spoken Swedish

Patient with pacemaker and/or ICD or other electronic implants

Patient with impaired sensation over the painful area

Malignant disease with an expected survival <12 months

Trial design

Treatments tested in this trial

  • Transcutaneous electrical nerve stimulation (TENS)
  • Conventional analgesic treatment

Treatment groups

40 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Göteborg University

Lead sponsor

Vastra Gotaland Region

Collaborator